Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander?

被引：61

作者：

Desmedt, Valerie ^{[1
]}

Desmedt, Stephanie ^{[1
]}

Delanghe, Joris R. ^{[2
]}

Speeckaert, Reinhart ^{[2
]}

Speeckaert, Marijn M. ^{[1
]}

机构：

[1] Ghent Univ Hosp, Dept Nephrol, De Pintelaan 185, BE-9000 Ghent, Belgium

[2] Ghent Univ Hosp, Dept Clin Chem, BE-9000 Ghent, Belgium

来源：

AMERICAN JOURNAL OF NEPHROLOGY | 2016年 / 43卷 / 05期

关键词：

Galectin-3; Kidney disease; Lectin; Renal fibrosis; CARBOHYDRATE-RECOGNITION DOMAIN; FAMILIAL MEDITERRANEAN FEVER; POLYCYSTIC KIDNEY-DISEASE; HEART-FAILURE PATIENTS; EPITHELIAL-CELLS; KNOCKOUT MICE; HYPERTENSIVE NEPHROPATHY; INTERSTITIAL FIBROSIS; DIABETIC-NEPHROPATHY; SERUM GALECTIN-3;

D O I：

10.1159/000446376

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Galectin-3 is a member of a closely related lectin family, which is detected in several vertebrate epithelial and myeloid cell types. This beta-galactoside-binding soluble protein plays an important role in multiple biological processes. Depending on its location, type of injury or site of damage, the effects by galectin-3 can be various and sometimes contrasting. Summary: In this review, we discuss the general characteristics and functions of galectin-3. More specifically, we focus on the role of galectin-3 in the onset and development of diabetic and non-diabetic nephropathies. Finally, the therapeutic potential of anti-galectin-3 inhibitors is discussed. Key Messages: Due to its multifunctional character, galectin-3 plays a pivotal role in interstitial fibrosis and progression of chronic kidney disease. Inhibition of galectin-3 may be a promising therapeutic strategy to prevent end-stage renal disease. (C) 2016 S. Karger AG, Basel

引用

页码：305 / 317

页数：13

共 92 条

[81]

2-D

[82]

Vansthertem D, 2010, HISTOL HISTOPATHOL, V25, P1417, DOI 10.14670/HH-25.1417

[83] Galectins as Pattern Recognition Receptors: Structure, Function, and Evolution [J].

Vasta, Gerardo R. .

CURRENT TOPICS IN INNATE IMMUNITY II, 2012, 946 :21-36

[84] Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain [J].

Vijayakumar, Soundarapandian ;

Peng, Hu ;

Schwartz, George J. .

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2013, 305 (01) :F90-F99

[85] Protein glycation in the kidney: Role in diabetes and aging [J].

Vlassara, H ;

Cohen, JJ ;

Madias, NE ;

Harrington, JT ;

Zusman, CJ ;

Williams, ME ;

Levey, AS ;

Pereira, B ;

Lafayette, R ;

Beasley, D .

KIDNEY INTERNATIONAL, 1996, 49 (06) :1795-1804

[86] IDENTIFICATION OF GALECTIN-3 AS A HIGH-AFFINITY BINDING-PROTEIN FOR ADVANCED GLYCATION END-PRODUCTS (AGE) - A NEW MEMBER OF THE AGE-RECEPTOR COMPLEX [J].

VLASSARA, H ;

LI, YM ;

IMANI, F ;

WOJCIECHOWICZ, D ;

YANG, Z ;

LIU, FT ;

CERAMI, A .

MOLECULAR MEDICINE, 1995, 1 (06) :634-646

[87] Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma [J].

von Klot, Christoph-A ;

Kramer, Mario W. ;

Peters, Inga ;

Hennenlotter, Joerg ;

Abbas, Mahmoud ;

Scherer, Ralph ;

Herrmann, Thomas R. W. ;

Stenzl, Arnulf ;

Kuczyk, Markus A. ;

Serth, Juergen ;

Merseburger, Axel S. .

BMC CLINICAL PATHOLOGY, 2014, 14

[88] Ligand binding and complex formation of galectin-3 is modulated by pH variations [J].

von Mach, Tobias ;

Carlsson, Michael C. ;

Straube, Tamara ;

Nilsson, Ulf ;

Leffler, Hakon ;

Jacob, Ralf .

BIOCHEMICAL JOURNAL, 2014, 457 :107-115

[89] Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout mice [J].

Watson, Anna M. D. ;

Li, Jiaze ;

Samijono, Dian ;

Bierhaus, Angelika ;

Thomas, Merlin C. ;

Jandeleit-Dahm, Karin A. M. ;

Cooper, Mark E. .

ATHEROSCLEROSIS, 2014, 235 (02) :444-448

[90]

Winyard PJD, 1997, J AM SOC NEPHROL, V8, P1647

← 1 2 3 4 5 6 7 8 9 10 →